This segment encompasses the operation of Rede D'Or's extensive network of hospitals across Brazil. It includes providing a wide array of medical services, including but not limited to neurology, oncology, cardiology, and surgery. The hospitals are equipped with advanced technologies such as robotic surgery facilities. Research and development activities within this segment focus on improving patient outcomes and operational efficiency. This includes the implementation of AI-powered pathology solutions through partnerships. The segment's market positioning is as the largest private hospital network in Brazil, offering a competitive advantage through its scale, quality of care, and geographic reach. Future opportunities include expansion of services, adoption of new technologies, and strategic partnerships to enhance patient care and operational excellence. Regulatory compliance and patient safety are paramount, ensuring adherence to Brazilian healthcare standards. The segment also benefits from collaborations with research institutions and strategic partnerships with insurance providers.

This segment focuses on the diagnosis and treatment of cancer, operating 47 oncology clinics. Rede D'Or provides comprehensive cancer care, including diagnosis, treatment, and supportive services. Research and development efforts are directed towards improving cancer treatment methodologies, including exploring new therapies and treatment protocols. The segment utilizes advanced technologies such as medical imaging and radiation therapy. The therapeutic areas covered include various types of cancer, with a focus on improving patient outcomes and quality of life. Rede D'Or's market position is strengthened by its comprehensive cancer care services and its commitment to innovation. Future opportunities include expanding the range of cancer treatments offered, investing in advanced technologies, and participating in clinical trials. The segment adheres to strict regulatory guidelines and clinical validation processes to ensure patient safety and treatment effectiveness. Partnerships with research institutions and pharmaceutical companies are crucial for advancing cancer care.